News Industry News NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation April 26, 2017
News Daily News Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings Shelley Wood January 19, 2017
News Industry News Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events November 02, 2016
News Industry News TCT 2016 Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke November 01, 2016
Presentation TCT 2016 Devices for the Right Heart (Tricuspid and Pulmonic Valves) Presenter: Blase A. Carabello, George D. Dangas, Colin M. Barker November 01, 2016
Presentation TCT 2016 Transcatheter Mitral Valve Replacement Presenter: Blase A. Carabello, George D. Dangas, Howard C. Herrmann November 01, 2016
Presentation TCT 2016 Transcatheter Mitral Valve Repair: Results With Approved Devices (US and OUS) Presenter: Blase A. Carabello, George D. Dangas, Alec S. Vahanian November 01, 2016
Presentation TCT 2016 Future TAVR Devices and Adjunctive Therapies Presenter: Blase A. Carabello, George D. Dangas November 01, 2016
Presentation TCT 2016 TAVR: Current Status of Devices and Indications Presenter: Blase A. Carabello, George D. Dangas, Vinod H. Thourani November 01, 2016
Presentation TCT 2016 Debate: Is Left Atrial Appendage Closure Underutilized? No, NOACs Have the Best Efficacy and Safety Profile for Most Patients! Presenter: Andreas Baumbach, David Hildick-Smith, Jai-Wun Park November 01, 2016
Presentation TCT 2016 Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to All Patients With Atrial Fibrillation (I Would Want It!) Presenter: Andreas Baumbach, David Hildick-Smith, Ted Feldman November 01, 2016
Presentation TCT 2016 Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients! Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto November 01, 2016
Presentation TCT 2016 Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy! Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen November 01, 2016
News Industry News Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance November 01, 2016
News Industry News Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients November 01, 2016
News Industry News TCT 2016 Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement November 01, 2016
News Daily News First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement Shelley Wood July 11, 2016
News Conference News TVT 2016 What TAVR Needs Next . . . and What It’s Getting Shelley Wood June 17, 2016
News Daily News Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis Michael O'Riordan June 07, 2016
News Conference News EuroPCR 2016 As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease Shelley Wood May 18, 2016